Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

2 terminated/withdrawn out of 10 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 1

1(12.5%)

8Total

N/A(7)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT05573334Not ApplicableCompleted

Vaginal Care System for Menopausal Women With Urinary Tract Infections

Role: lead

NCT05372770Not ApplicableCompleted

Flourish Vaginal Care System to Establish Neovaginal Microbiome

Role: lead

NCT06472765Enrolling By Invitation

Vaginal Ecosystem and Network in the United States Study

Role: lead

NCT05390606Phase 1Terminated

Effects of Flourish HEC and BioGenesis to Improve Conception

Role: lead

NCT05386147Not ApplicableCompleted

Flourish HEC to Prevent Recurrence of BV

Role: lead

NCT05701722Not ApplicableCompleted

Effect of Flourish HEC Vaginal Care System on BV Recurrence and the Vaginal Microbiome

Role: lead

NCT05397782Not ApplicableCompleted

Effects of Flourish on Recurrent Urinary Tract Infection

Role: lead

NCT05478746Not ApplicableCompleted

Effects of Flourish HEC on Localized Provoked Vulvodynia

Role: lead

NCT05665569Not ApplicableTerminated

Effects of Flourish HEC Vaginal Care System on Birth-Related Pelvic Floor Disorders

Role: lead

NCT03734523Completed

Clinical Trial to Survey Results of Flourish Vaginal Care System for Recurrent Bacterial Vaginosis

Role: lead

All 10 trials loaded